https://orcid.org/0000-0002-4439-6866
Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Philip J. Kuehl, Christin M. Yingling, Devon Dubose, Michael Burke, David A. Revelli, Wenshu Chen, Wendy W. Dye, Steven A. Belinsky & Mathewos Tessema. (2021) Inhalation delivery dramatically improves the efficacy of topotecan for the treatment of local and distant lung cancer. Drug Delivery 28:1, pages 767-775.
Read now
Read now
Articles from other publishers (4)
Suyash M. Patil, Druva Sarika Barji, Sophia Aziz, David A. McChesney, Shapali Bagde, Pavan Muttil & Nitesh K. Kunda. (2023) Pulmonary delivery of spray-dried Nisin ZP antimicrobial peptide for non-small cell lung cancer (NSCLC) treatment. International Journal of Pharmaceutics 634, pages 122641.
Crossref
Crossref
Yun Zheng, Jing Xia & Jisheng Zheng. (2022) Application of Acupoint Catgut Embedding Therapy Combined with Liuzijue Breathing Exercise in the Treatment of Patients with Stable Chronic Obstructive Pulmonary Disease. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-9.
Crossref
Crossref
Jiaxing Zhang, Yihong Xie, Joey Sum-wing Kwong, Long Ge, Rui He, Wenyi Zheng, Jing Han, Rui Zhang, Huaye Zhao, Yuru He & Xiaosi Li. (2021) The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review. Frontiers in Pharmacology 12.
Crossref
Crossref
Christopher Hvisdas. (2021) Revefenacin, a once-daily, long-acting muscarinic antagonist, for nebulized maintenance therapy in patients with chronic obstructive pulmonary disease. American Journal of Health-System Pharmacy 78:13, pages 1184-1194.
Crossref
Crossref